Soligenix Inc (NASDAQ: SNGX) shares soared 25.9620% to end trading Tuesday at $1.31 per share – a net change of $0.27. Shares traded between $1.32 and $1.02 throughout the day.
About Soligenix Inc
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.